🔎 Trials Near Me

Hjem › Myelodysplastiske syndromer › Indiana

Kliniske studier for Myelodysplastiske syndromer i Indiana

4 studier for Myelodysplastiske syndromer søker deltakere på steder i Indiana.

Byer i Indiana

Offisiell studietekst (engelsk)

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

  • UChicago Medicine Northwest Indiana, Crown Point
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06577441

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05564390

Collection of Tissue Samples for Cancer Research

  • Indiana University - Purdue, Indianapolis
RekruttererObservasjonsstudie
2 Months · Alle kjønn · Oppdatert 16. sep. 2026 · NCT00900198

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Riley Hospital for Children, Indianapolis
  • Ascension Saint Vincent Indianapolis Hospital, Indianapolis
RekruttererFase 1/2
Opp til 22 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04726241

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.